دورية أكاديمية
أعرض في EDS

Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements.

التفاصيل البيبلوغرافية
العنوان: Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements.
المؤلفون: Mes SD; Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, Postbus 9600, Leiden, RC, The Netherlands. s.d.mes@lumc.nl., van der Jagt MA; Department of Otolaryngology, Alrijne Hospital, Leiden, The Netherlands., Jansen JC; Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, Postbus 9600, Leiden, RC, The Netherlands., Langeveld APM; Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, Postbus 9600, Leiden, RC, The Netherlands., Sjögren EV; Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, Postbus 9600, Leiden, RC, The Netherlands., Heijnen BJ; Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, Postbus 9600, Leiden, RC, The Netherlands.
المصدر: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 May; Vol. 281 (5), pp. 2499-2505. Date of Electronic Publication: 2024 Feb 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9002937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-4726 (Electronic) Linking ISSN: 09374477 NLM ISO Abbreviation: Eur Arch Otorhinolaryngol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Heidelberg : Springer International, c1990-
مواضيع طبية MeSH: Laryngoplasty* , Voice* , Vocal Cord Paralysis*/surgery, Humans ; Prospective Studies ; Voice Quality ; Arytenoid Cartilage/surgery ; Treatment Outcome
مستخلص: Purpose: Arytenoid adduction as an addition to medialisation thyroplasty is highly advocated by some surgeons in selected cases but deemed less necessary by others in patients with unilateral vocal fold paralysis. This study aims to evaluate the additional benefits on voice outcome of arytenoid adduction in patients with unilateral vocal fold paralysis undergoing medialisation thyroplasty using intra-operative voice measurements.
Design/methods: A prospective study was conducted. Voice audio recordings were obtained at 4 moments; 1. direct prior to the start of surgery, 2. during surgery after medialisation thyroplasty, 3. during surgery after medialisation and arytenoid adduction, 3 months postoperative. At these same timepoints patients rated their own voice on a numeric rating scale between 0 and 10. The blinded recordings were rated by consensus in a team of experienced listeners, using the Grade of the GRBAS scale. Furthermore, the Voice Handicap Index was administered before and at 3 months after surgery.
Results: Ten patients who underwent medialisation and arytenoid adduction at our tertiary referral hospital between 2021 and 2022, were included. One patient was excluded after surgery. The intraoperative measurements showed a Grade score of 1.4 preoperatively, improving to 1.2 after medialisation, 1.2 after medialisation and arytenoid adduction, and further improving to 0.4 at 3 months postoperative, which was a not statistically significant improvement (p = 0.2). The intraoperative subjective numeric rating scale showed a statistically significant improvement from 3.9 preoperatively, to 6.1 after medialisation, 7.1 after medialisation and arytenoid adduction and a 7.6 at 3 months postoperative (p = 0.001). The Voice Handicap Index total score showed a statistically significant improvement from 71 points before surgery to 13 at 3 months after surgery (p = 0.008).
Conclusions: Our study using intraoperative voice measurements indicate that the addition of arytenoid adduction to medialisation thyroplasty is a benefit in selected patients although more studies are needed due to the many limitations inherent to this field of investigation.
(© 2024. The Author(s).)
References: Eur Arch Otorhinolaryngol. 2020 Mar;277(3):809-817. (PMID: 31845039)
Acta Otolaryngol. 1975 Nov-Dec;80(5-6):465-73. (PMID: 1202920)
Laryngoscope. 2017 Nov;127(11):2591-2595. (PMID: 28699172)
Ann Otol Rhinol Laryngol. 2022 Aug;131(8):859-867. (PMID: 34535066)
J Voice. 1998 Mar;12(1):107-11. (PMID: 9619986)
J Chronic Dis. 1974 Sep;27(7-8):387-404. (PMID: 4436428)
Otolaryngol Head Neck Surg. 2003 Oct;129(4):305-10. (PMID: 14574281)
Laryngoscope Investig Otolaryngol. 2022 Aug 22;7(5):1481-1490. (PMID: 36258849)
J Laryngol Otol. 2021 Feb;135(2):159-167. (PMID: 33593469)
J Voice. 2015 Mar;29(2):236-40. (PMID: 25510165)
J Voice. 2020 Jul;34(4):649.e1-649.e6. (PMID: 30616964)
Laryngoscope. 2015 Dec;125(12):2772-7. (PMID: 26198167)
Curr Otorhinolaryngol Rep. 2014 Jun 1;2(2):119-130. (PMID: 24883239)
Eur Arch Otorhinolaryngol. 2022 Apr;279(4):1957-1965. (PMID: 34787700)
Laryngoscope. 2000 Aug;110(8):1306-11. (PMID: 10942131)
Laryngoscope. 2019 Aug;129(8):1876-1881. (PMID: 30582612)
Folia Phoniatr Logop. 2006;58(2):132-8. (PMID: 16479134)
Laryngoscope. 2001 Aug;111(8):1322-9. (PMID: 11568563)
Arch Otolaryngol. 1978 Oct;104(10):555-8. (PMID: 697632)
J Voice. 2011 May;25(3):259-64. (PMID: 20335002)
Acta Otorrinolaringol Esp. 2012 Sep-Oct;63(5):364-9. (PMID: 22633785)
Laryngoscope Investig Otolaryngol. 2020 Sep 30;5(5):895-902. (PMID: 33134537)
فهرسة مساهمة: Keywords: Arytenoid adduction; Medialisation thyroplasty; VHI; Vocal fold paralysis; Voice outcome
تواريخ الأحداث: Date Created: 20240216 Date Completed: 20240418 Latest Revision: 20240425
رمز التحديث: 20240425
مُعرف محوري في PubMed: PMC11023975
DOI: 10.1007/s00405-024-08494-3
PMID: 38365991
قاعدة البيانات: MEDLINE
الوصف
تدمد:1434-4726
DOI:10.1007/s00405-024-08494-3